|View printer-friendly version|
G1 Therapeutics to Present at Investor Conferences in March 2018
Cowen and Company38th Annual Healthcare Conference: Monday, March 12at 11:20 a.m. ETat the Marriott Copley Placein Boston, MA. Needham & Company17th Annual Healthcare Conference: Tuesday, March 27at 8:30 a.m. ETat the Westin Grand Central Hotelin New York, NY.
To access the live webcasts of the presentations, please visit the Events & Presentations page within the Investors section of the G1 website. Replays of the webcast will be archived on the same page for 30 days following the event.
G1 is based in Research Triangle Park, NC. For additional information, please visit www.g1therapeutics.com and follow us on Twitter @G1Therapeutics.
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Words such as "may," "will," "expect," "plan," "anticipate," "estimate," "intend" and similar expressions (as well as other words or expressions referencing future events, conditions or circumstances) are intended to identify forward-looking statements. Forward-looking statements in this news release include, but are not limited to, the therapeutic potential of trilaciclib, G1T38 and G1T48, and are based on G1 Therapeutics’ expectations and assumptions as of the date of this press release. Each of these forward-looking statements involves risks and uncertainties. Factors that may cause G1 Therapeutics’ actual results to differ from those expressed or implied in the forward-looking statements in this press release are discussed in G1 Therapeutics’ filings with the
Head of Investor Relations / Public Relations